Equities

Krsnaa Diagnostics Ltd

KRSNAA:NSI

Krsnaa Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)911.55
  • Today's Change11.55 / 1.28%
  • Shares traded69.40k
  • 1 Year change+43.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,7521,0882,443
Total Receivables, Net1,954800661
Total Inventory436286111
Prepaid expenses463357
Other current assets, total242270
Total current assets4,2122,2293,341
Property, plant & equipment, net6,5464,9334,116
Goodwill, net------
Intangibles, net242823
Long term investments1511,5561,158
Note receivable - long term3741226.89
Other long term assets165155--
Total assets11,7199,0998,762
LIABILITIES
Accounts payable823621773
Accrued expenses17312922
Notes payable/short-term debt957060
Current portion long-term debt/capital leases2228219
Other current liabilities, total639160613
Total current liabilities2,8159921,488
Total long term debt419243331
Total debt1,598325410
Deferred income tax16412878
Minority interest------
Other liabilities, total22334921
Total liabilities3,6211,7121,917
SHAREHOLDERS EQUITY
Common stock161157157
Additional paid-in capital6,6086,380--
Retained earnings (accumulated deficit)1,3218426,687
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total7.488.810
Total equity8,0987,3876,844
Total liabilities & shareholders' equity11,7199,0998,762
Total common shares outstanding323131
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.